1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Ischemia Reperfusion Injury: new trials by email Literature Review of Ischemia Reperfusion Injury trials Research Report on Ischemia Reperfusion Injury
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation Treprostinil - Ischemia Reperfusion Injury, Delayed Graft Function | Phase 1 / Phase 2 | Recruiting | Rhode Island Hospital | 20 | 2020-11-13 | 2026-04-23 |
| Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI) Allogeneic adipose derived mesenchymal stem cells - Ischemia Reperfusion Injury | Phase 1 | Withdrawn | Tambi Jarmi | 2020-09-01 | 2023-10-18 | |
| Intravenous Estrogen in Kidney Transplant Study Conjugated Estrogen, Normal saline - Ischemia Reperfusion Injury | Phase 1 / Phase 2 | Active not recruiting | University of Pennsylvania | 30 | 2016-08-26 | 2026-04-16 |
| Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation Treprostinil - Ischemia Reperfusion Injury | Phase 1 | Completed | Abhinav Humar, MD | 35 | 2012-12-01 | 2023-12-15 |
| Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery Bendavia, Placebo - Renal Artery Obstruction, Hypertension, Renovascular | Phase 1 / Phase 2 | Terminated | Stealth BioTherapeutics Inc. | 16 | 2012-12-01 | 2020-08-11 |
Reperfusion Injury (5) · Delayed Graft Function (1) · Hypertension, Renovascular (1) · Renal Artery Obstruction (1)
Cardiovascular Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Postoperative Complications (5) · Vascular Diseases (5) · Arterial Occlusive Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hypertension (1) · Hypertension, Renal (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
treprostinil (2) · Estrogens, Conjugated (USP) (1) · Saline Solution (1) · Sodium Chloride (1) · arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide (1)
Abhinav Humar, MD (1) · Rhode Island Hospital (1) · Stealth BioTherapeutics Inc. (1) · Tambi Jarmi (1) · University of Pennsylvania (1)
United States (4)
Abhinav Humar, M.D. (1) · Matthew Levine, MD, PhD (1) · Richard Straube, MD (1) · Stephen C Textor, MD (1) · Tambi Jarmi, MD (1)
PMID 10231466, PMID 12219027, PMID 12234307, PMID 12389082, PMID 15251365, PMID 15358759, PMID 15618244, PMID 15670785, PMID 15698835, PMID 17336333, PMID 1963650, PMID 19638737, PMID 21274961, PMID 21398592, PMID 21658244, PMID 21691090, PMID 22572084, PMID 23552495, PMID 27088798, PMID 2850395, PMID 28916603, PMID 3018561, PMID 6281704, PMID 9112349